Immune imprinting as a barrier to effective COVID-19 vaccines
- PMID: 37992689
- PMCID: PMC10694758
- DOI: 10.1016/j.xcrm.2023.101291
Immune imprinting as a barrier to effective COVID-19 vaccines
Abstract
Wang and colleagues show that immune imprinting impairs neutralizing antibody titers for bivalent mRNA vaccination against SARS-CoV-2 Omicron subvariants. Imprinting from three doses of monovalent vaccine can be alleviated by BA.5 or BQ-lineage breakthrough infection but not by a bivalent booster.1.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine.Cell Rep Med. 2023 Nov 21;4(11):101258. doi: 10.1016/j.xcrm.2023.101258. Epub 2023 Oct 30. Cell Rep Med. 2023. PMID: 37909042 Free PMC article.
References
-
- Wang Q., Guo Y., Tam A.R., Valdez R., Gordon A., Liu L., Ho D.D. Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine. Cell Rep. Med. 2023;4 - PubMed
-
- Francis T. On the Doctrine of Original Antigenic Sin. Proc. Am. Phil. Soc. 1960;104:572–578.
-
- Evans J.P., Liu S.-L. Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies. J. Immunol. 2023 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
